While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and the best treatment outcomes.

I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...

Discover how driving innovation in multiple myeloma treatment can positively impact the patient experience. Stay informed on the latest advancements in cancer research and patient care.

FDA approves earlier use of J&J's BCMA CAR-T therapy Carvykti and BMS' rival Abecma for earlier use in multiple myeloma.

Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...

Myeloma articles from across Nature Portfolio Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 ...